ARDTArdent Health Partners Inc. Common Stock

Investors need to pay close attention to ARDT stock based on the movements in the options market lately.

Surgical volumes declined, but operational savings helped offset revenue pressure.

Ardent Health earnings and guidance reset Ardent Health (ARDT) reported second quarter 2026 results on 4 August, with net income and earnings per share lower than a year earlier and full year earnings guidance reduced. The company paired this softer outlook with an update on its ongoing share buyback program, which has now retired more than 1.2% of outstanding shares. See our latest analysis for Ardent Health. Ardent Health shares have had a strong run in 2026, with a 33.68% year to date...

ARDX, ARDT and GPRE have been added to the Zacks Rank #5 (Strong Sell) List on August 7th, 2026.

Ardent Health Inc (ARDT) boosts cost savings guidance and secures key payer contract renewal, but navigates broad-based volume declines and a cautious second-half outlook.

Ardent Health (NYSE:ARDT) reported second-quarter revenue of $1.62 billion and adjusted EBITDA of $115 million, as management said cost controls, a favorable payer contract renewal and strong cash flow helped offset weaker-than-expected volumes. Surgeries and admissions were pressured during April

Moby summary of Ardent Health Partners, LLC's Q2 2026 earnings call

Ardent Health, Inc. (ARDT) delivered earnings and revenue surprises of -29.41% and +1.96%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Labcorp (LH) delivered earnings and revenue surprises of +4.18% and +0.36%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Icon PLC (ICLR) delivered earnings and revenue surprises of -0.39% and +3.48%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Charles River (CRL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Ardent Health, Inc. (ARDT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Elevance Health (ELV) delivered earnings and revenue surprises of +20.55% and +2.85%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?